WallStSmart

CME Group Inc (CME)vsFactSet Research Systems Inc (FDS)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

CME Group Inc generates 177% more annual revenue ($6.76B vs $2.44B). CME leads profitability with a 63.4% profit margin vs 23.2%. FDS appears more attractively valued with a PEG of 1.27. FDS earns a higher WallStSmart Score of 62/100 (C+).

CME

Buy

55

out of 100

Grade: C-

Growth: 4.7Profit: 8.0Value: 4.3Quality: 4.5
Piotroski: 1/9Altman Z: -0.67

FDS

Buy

62

out of 100

Grade: C+

Growth: 4.7Profit: 9.0Value: 5.7Quality: 5.5
Piotroski: 4/9Altman Z: 2.57

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CME4 strengths · Avg: 9.5/10
Profit MarginProfitability
63.4%10/10

Keeps 63 of every $100 in revenue as profit

Operating MarginProfitability
65.0%10/10

Strong operational efficiency at 65.0%

Market CapQuality
$99.08B9/10

Large-cap with strong market position

Debt/EquityHealth
0.139/10

Conservative balance sheet, low leverage

FDS3 strengths · Avg: 9.3/10
Operating MarginProfitability
30.5%10/10

Strong operational efficiency at 30.5%

Return on EquityProfitability
27.6%9/10

Every $100 of equity generates 28 in profit

Profit MarginProfitability
23.2%9/10

Keeps 23 of every $100 in revenue as profit

Areas to Watch

CME4 concerns · Avg: 3.3/10
Revenue GrowthGrowth
0.8%4/10

0.8% revenue growth

EPS GrowthGrowth
2.5%4/10

2.5% earnings growth

Piotroski F-ScoreQuality
1/93/10

Weak financial health signals

PEG RatioValuation
4.782/10

Expensive relative to growth rate

FDS1 concerns · Avg: 2.0/10
EPS GrowthGrowth
-9.6%2/10

Earnings declined 9.6%

Comparative Analysis Report

WallStSmart Research

Bull Case : CME

The strongest argument for CME centers on Profit Margin, Operating Margin, Market Cap. Profitability is solid with margins at 63.4% and operating margin at 65.0%.

Bull Case : FDS

The strongest argument for FDS centers on Operating Margin, Return on Equity, Profit Margin. Profitability is solid with margins at 23.2% and operating margin at 30.5%. PEG of 1.27 suggests the stock is reasonably priced for its growth.

Bear Case : CME

The primary concerns for CME are Revenue Growth, EPS Growth, Piotroski F-Score.

Bear Case : FDS

The primary concerns for FDS are EPS Growth.

Key Dynamics to Monitor

CME profiles as a value stock while FDS is a mature play — different risk/reward profiles.

FDS carries more volatility with a beta of 0.71 — expect wider price swings.

FDS is growing revenue faster at 6.4% — sustainability is the question.

CME generates stronger free cash flow (924M), providing more financial flexibility.

Bottom Line

FDS scores higher overall (62/100 vs 55/100), backed by strong 23.2% margins. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

CME Group Inc

FINANCIAL SERVICES · FINANCIAL DATA & STOCK EXCHANGES · USA

CME Group Inc. (Chicago Mercantile Exchange, Chicago Board of Trade, New York Mercantile Exchange, The Commodity Exchange) is an American global markets company. It is the world's largest financial derivatives exchange, and trades in asset classes that include agricultural products, currencies, energy, interest rates, metals, stock indexes and cryptocurrencies futures.

Visit Website →

FactSet Research Systems Inc

FINANCIAL SERVICES · FINANCIAL DATA & STOCK EXCHANGES · USA

FactSet Research Systems Inc. provides integrated financial information and analytical applications to investment and corporate communities in the Americas, EMEA, and Asia Pacific. The company is headquartered in Norwalk, Connecticut.

Want to dig deeper into these stocks?